2011KTH Publication Database DiVA (KTH Royal Institute of Technology)Open access

A galanin(2-11) analogue specific for GalR2

Johan Runesson, Kristin Karlsson, Ülo Langel

Open full text 0 citations

Abstract

The neuropeptide galanin family currently consists of four members, namely galanin, galanin-message-associated peptide (GMAP), galanin-like peptide (GALP) and alarin. Galanin has been shown to influence several physiological processes including cognition, affective behavior, nerve injury, Alzheimer’s disease, neuroregeneration, seizures, feeding, and hormone release. The co-localization with other neuromodulators and the distinct up-regulation during and after pathological disturbances has drawn attention to this neuropeptide family. The regionally specific expression of the galanin receptors (GalR1-3) suggests different physiological roles, a feature which mostly remains unexplored due to the lack of stable, selective and potent ligands acting on the galanin receptor subtypes. The introduction of galanin(2-11) as a GalR2 selective ligand was an important advance in the galanin field. Unfortunately, later publications described that galanin(2-11) also binds with similar affinity to GalR3, a critical limitation when delineating the interplay between galanin receptor subtypes. Even so, galanin(2-11) has been given extensive attention and been used in numerous study as a non-GalR1 ligand. We now introduce an analogue of galanin(2-11) that combines the GalR2 selective binding, comparable with the published M1145 with the small size of galanin(2-11). Utilizing this true GalR2 selective ligand will help to define the role GalR2 in general and especially for already published studies that has been exploit galanin(2-11).

About this research paper

What this paper is about

The neuropeptide galanin family currently consists of four members, namely galanin, galanin-message-associated peptide (GMAP), galanin-like peptide (GALP) and alarin. Galanin has been shown to influence several physiological processes including cognition, affective behavior, nerve injury, Alzheimer’s disease, neuroregeneration, seizures, feeding, and hormone release. The co-localization with other neuromodulators and the distinct up-regulation during and after pathological disturbances has drawn attention to this neuropeptide family. The regionally specific expression of the galanin receptors (GalR1-3) suggests different physiological roles, a feature which mostly remains unexplored due to the lack of stable, selective and potent ligands acting on the galanin receptor subtypes. The introduction of galanin(2-11) as a GalR2 selective ligand was an important advance in the galanin field. Unfortunately, later publications described that galanin(2-11) also binds with similar affinity to GalR3, a critical limitation when delineating the interplay between galanin receptor subtypes. Even so, galanin(2-11) has been given extensive attention and been used in numerous study as a non-GalR1 ligand. We now introduce an analogue of galanin(2-11) that combines the GalR2 selective binding, comparable with the published M1145 with the small size of galanin(2-11). Utilizing this true GalR2 selective ligand will help to define the role GalR2 in general and especially for already published studies that has been exploit galanin(2-11).

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The neuropeptide galanin family currently consists of four members, namely galanin, galanin-message-associated peptide (GMAP), galanin-like peptide (GALP) and alarin. Galanin has been shown to influence several physiological processes including cognition, affective behavior, nerve injury, Alzheimer’s disease, neuroregeneration, seizures, feeding, and hormone release. The co-localization with other neuromodulators and the distinct up-regulation during and after pathological disturbances has drawn attention to this neuropeptide family. The regionally specific expression of the galanin receptors (GalR1-3) suggests different physiological roles, a feature which mostly remains unexplored due to the lack of stable, selective and potent ligands acting on the galanin receptor subtypes. The introduction of galanin(2-11) as a GalR2 selective ligand was an important advance in the galanin field. Unfortunately, later publications described that galanin(2-11) also binds with similar affinity to GalR3, a critical limitation when delineating the interplay between galanin receptor subtypes. Even so, galanin(2-11) has been given extensive attention and been used in numerous study as a non-GalR1 ligand. We now introduce an analogue of galanin(2-11) that combines the GalR2 selective binding, comparable with the published M1145 with the small size of galanin(2-11). Utilizing this true GalR2 selective ligand will help to define the role GalR2 in general and especially for already published studies that has been exploit galanin(2-11).

Key concepts: Galanin, Galanin receptor, Neuropeptide, Internal medicine, Endocrinology, Biology, Receptor, Neuroscience

Related papers

Back to paper searchBrowse research topicsOriginal source
A galanin(2-11) analogue specific for GalR2 — Research Paper | ScholarLens